{
    "clinical_study": {
        "@rank": "18305", 
        "arm_group": {
            "arm_group_label": "Cetaphil Restoraderm Skin Restoring Body Wash", 
            "arm_group_type": "Experimental", 
            "description": "All subjects receive Cetaphil Daily Advance Ultra Hydrating Lotion"
        }, 
        "brief_summary": {
            "textblock": "Determine if Cetaphil Restoraderm Skin Restoring Body Wash proves to be a contact sensitizer\n      or irritant in certain individuals."
        }, 
        "brief_title": "Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body Wash", 
        "condition": "Skin Irritation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Not currently under a doctor's care\n\n          -  Free of dermatological or systemic disorder which would interfere with the results\n\n          -  Free of any acute or chronic disease\n\n          -  Will complete a preliminary medical history form and are in general good health\n\n          -  Can read, understand, and sign informed consent\n\n        Exclusion Criteria:\n\n          -  Under 18 years old\n\n          -  Currently under doctor's care\n\n          -  Currently taking any medication\n\n          -  History of acute or chronic disease\n\n          -  Diagnosed with chronic skin allergies\n\n          -  Pregnant or lactating"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 25, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01892410", 
            "org_study_id": "GLI.04.SRE.US10235"
        }, 
        "intervention": {
            "arm_group_label": "Cetaphil Restoraderm Skin Restoring Body Wash", 
            "description": "Diluted (10%) 0.2ml or 0.2g of Cetaphil on semi-occlusive, hypoallergenic patch applied to skin for 24 hrs 9 times on Monday, Wednesday, and Friday for 3 weeks", 
            "intervention_name": "Cetaphil Restoraderm Skin Restoring Body Wash", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 1, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "New City", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10956"
                }, 
                "name": "AMA Laboratories, Inc."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "100 Human Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Semi-Occlusive Patch)", 
        "overall_official": {
            "affiliation": "AMA Laboratories", 
            "last_name": "Mayya Tastene, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "9 consecutive 24hr exposures for every Monday, Wednesday, and Friday for 3 consecutive weeks", 
            "measure": "Area of irritation measured to determine sensitivity", 
            "safety_issue": "No", 
            "time_frame": "3 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01892410"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Galderma Laboratories, L.P.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Galderma Laboratories, L.P.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}